Busulphan
Blasts Under 5 Percent of Bone Marrow Nucleated Cells
Fred Hutchinson Cancer CenterPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Blasts Under 5 Percent of Bone Marrow Nucleated Cells cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine Fred Hutchinson Cancer Center | Phase 2 | BB |
CYCLOSPORIN A Fred Hutchinson Cancer Center | Phase 2 | B |
FILGRASTIM Fred Hutchinson Cancer Center | Phase 2 | B |
Cyclophosphamide Fred Hutchinson Cancer Center | Phase 2 | B |
Monomethyl Fumarate Fred Hutchinson Cancer Center | Phase 2 | B |
View all 12 →
Same molecule, other indications
Busulphan is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →